483
MolecularMD CorpMolecularMD Corp – FDA 483, May 29, 2026
Record Details
An FDA inspection of MolecularMD Corp in Portland, OR, revealed significant deficiencies in their quality management system. The firm failed to conduct adequate management reviews and internal audits for extended periods, and critical medical device suppliers were not properly monitored or re-evaluated. These observations indicate a systemic breakdown in maintaining essential quality controls.
View Company Profile
ID · e4ae622d-164c-4f38-ad31-5cf06a5ea6e3
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.